Lausanne University Hospital (CHUV)
Lausanne, Switzerland
Lausanne University Hospital (CHUV), based in Lausanne, Switzerland, has joined the IASIOS community as an Enrolled Centre. Under the leadership of Prof Rafael Duran, the team has taken an important step toward implementing structured, standardised care in interventional oncology.
CHUV is also a recipient of the First Year Forward Grant, which provides support during the early stages of the IASIOS pathway by covering enrolment and first-year membership fees.
We look forward to working with the team as they move forward in the accreditation process.
Aneurin Bevan University Health Board
Cwmbran, UK
Aneurin Bevan University Health Board has recently enrolled in the IASIOS community. The enrolment, led by Dr Nimit Goyal, reflects a clear commitment to standardised clinical care in interventional oncology.
The team is also a recipient of the First Year Forward Grant, which supports centres in the initial phase of their IASIOS journey.
We look forward to supporting them as they progress through the accreditation process.
CARTI
Little Rock, Arkansas
We are pleased to welcome CARTI in Little Rock, Arkansas, to the IASIOS community. CARTI’s enrolment reflects its commitment to high-quality, multidisciplinary cancer care and the advancement of interventional oncology. We are happy to see our community continue to grow in North America and look forward to supporting CARTI on their accreditation journey.
Tawam Hospital
Abu Dhabi, UAE
Tawam Hospital has joined the IASIOS community, marking an important step for interventional oncology in the United Arab Emirates. With a growing number of hospitals enrolling in IASIOS, the commitment to advancing high standards in interventional oncology continues to strengthen in the region. By working toward IASIOS accreditation, Tawam Hospital reinforces its dedication to delivering high-quality cancer care and continuous improvement in the field.
Santa Croce e Carle Hospital
Cuneo, Italy
Santa Croce e Carle Hospital has joined the IASIOS community, further expanding Italy’s presence as a leader in number of IASIOS Centres. With a growing number of hospitals enrolled and accredited, Italy continues to demonstrate a strong commitment to advancing standards in interventional oncology. By working toward IASIOS accreditation, Santa Croce e Carle Hospital is reinforcing its dedication to high-quality cancer care and continuous improvement in the field.
Instituto Oncológico Nacional de Panamá
Panama City, Panama
Congratulations to Instituto Oncológico Nacional de Panamá on becoming the first center in Panama to join the IASIOS community. This important milestone reflects their commitment to advancing the quality of cancer care and working toward IASIOS accreditation.
CHU de São João
Porto, Portugal
IASIOS is proud to welcome CHU de São João as a new Enrolled Centre.
Joining IASIOS reflects the centre’s strong commitment to advancing interventional oncology through robust quality assurance, patient-focused care, and alignment with internationally recognised standards.
As part of the IASIOS community, CHU de São João becomes part of a global network of institutions dedicated to enhancing cancer care through collaboration, continuous improvement, and the sharing of best practices.
We are pleased to accompany the team at CHU de São João as they embark on their journey toward IASIOS accreditation.
Auckland City Hospital
Auckland, New Zealand
München Klinik Bogenhausen
Munich, Germany
IASIOS is pleased to welcome München Klinik Bogenhausen as a new Enrolled Centre.
The enrolment marks a step forward in the clinic’s continued efforts to strengthen and further structure its interventional oncology offering. A key focus is the ongoing development of coordinated treatment pathways, enhanced multidisciplinary collaboration, and the consistent application of high standards in clinical practice and patient care.
By joining IASIOS, München Klinik Bogenhausen becomes part of an international network dedicated to improving interventional oncology through shared learning, benchmarking, and the practical exchange of expertise across institutions.
We look forward to accompanying the team as they progress on their pathway toward accreditation.
University Medical Center Freiburg
Freiburg, Germany
IASIOS is pleased to welcome University Medical Center Freiburg as a new Enrolled Centre.
This step reflects the centre’s commitment to strengthening interventional oncology within a structured framework focused on quality, consistency, and patient-centred care. Engagement with IASIOS supports further alignment with internationally recognised standards and the continued development of multidisciplinary cancer pathways.
As part of the IASIOS network, University Medical Center Freiburg joins a global community dedicated to advancing excellence in interventional oncology through collaboration and continuous improvement.
We look forward to supporting the team on their pathway toward accreditation.